Literature DB >> 34697204

A Rare Thymic Tumor - Lipofibroadenoma - Always a Postoperative Surprise.

Ciprian Bolca1,2,3, Alexandru Has1,4, Andrei Bobocea1,5, Adelina Afetelor1, Radu Stoica6, Irina Strambu5,7, Ileana Stoicescu7, Elena Magheran8, Irina Balescu9, Nicolae Bacalbasa10,11, Florentina Gherghiceanu12, Florentina Furtunescu13, Daniel Radavoi14,15, Camelia Diaconu16,17, Cristian Paleru1,5, Ioan Cordos1,5.   

Abstract

BACKGROUND/AIM: Thymic lipofibroadenoma is a benign growth of unknown etiology extremely rarely described in the literature, morphologically resembling lipofibroadenoma of the breast. The diagnosis is usually a postoperative surprise and is made by the anatomopathologist. Surgical resection is curative. CASE REPORT: The presented case is the first reported in a woman, to date. The patient was successfully submitted to surgery and complete resection of the giant intrathoracic tumor was performed. The histopathological and immunohistochemical studies came to demonstrated the presence of a thymic lipofibroadenoma while the postoperative outcomes were favorable.
CONCLUSION: In cases presenting large intrathoracic tumors complete resection is able to provide a significant improvement of the general condition of the patient, as well as a chance for cure.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Thymic lipofibroadenoma; resection; thymic rare tumor

Mesh:

Year:  2021        PMID: 34697204      PMCID: PMC8627725          DOI: 10.21873/invivo.12668

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  10 in total

1.  Lipofibroadenoma with B1 thymoma: A case report of a rare thymic tumor.

Authors:  Monalisa Hui; Tara Roshni Paul; Shantveer G Uppin; Nirmala Jyothi
Journal:  Indian J Pathol Microbiol       Date:  2018 Oct-Dec       Impact factor: 0.740

2.  Histologic types of thymoma associated with pure red cell aplasia: a study of five cases including a composite tumor of organoid thymoma associated with an unusual lipofibroadenoma.

Authors:  T Kuo; L Y Shih
Journal:  Int J Surg Pathol       Date:  2001-01       Impact factor: 1.271

3.  Minimally invasive surgery in cancer. Immunological response.

Authors:  A C Bobocea; B Trandafir; C Bolca; I Cordoş
Journal:  Chirurgia (Bucur)       Date:  2012 Mar-Apr

4.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

5.  A rare thymoma type presenting as a giant intrathoracic tumor: lipofibroadenoma.

Authors:  Yener Aydin; Sare Sipal; Mine Celik; Omer Araz; Ali Bilal Ulas; Fatih Alper; Atila Eroglu
Journal:  Eurasian J Med       Date:  2012-12

6.  [Lipofibroadenoma of the thymus].

Authors:  Takuya Onuki; K Iguchi; M Inagaki; K Suzuki
Journal:  Kyobu Geka       Date:  2009-05

7.  Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy.

Authors:  Wouter K de Jong; Johannes L G Blaauwgeers; Michael Schaapveld; Wim Timens; Theo J Klinkenberg; Harry J M Groen
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

8.  Successful Resection of Giant Mediastinal Lipofibroadenoma of the Thymus by Video-Assisted Thoracoscopic Surgery.

Authors:  George Makdisi; Anja C Roden; K Robert Shen
Journal:  Ann Thorac Surg       Date:  2015-08       Impact factor: 4.330

9.  Thymofibrolipoma. A histologic variant of thymolipoma.

Authors:  C A Moran; H Zeren; M N Koss
Journal:  Arch Pathol Lab Med       Date:  1994-03       Impact factor: 5.534

10.  Lipofibroadenoma of the thymus: a case report.

Authors:  Guimei Qu; Guohua Yu; Qian Zhang; Junjie Ma; Xiaolei Wang
Journal:  Diagn Pathol       Date:  2013-07-15       Impact factor: 2.644

  10 in total
  1 in total

Review 1.  Thymofibrolipoma: a case report and review of the literature.

Authors:  Ryu Jokoji; Emiko Tomita
Journal:  Diagn Pathol       Date:  2022-10-12       Impact factor: 3.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.